Allergy Therapeutics plc (AGY.L) LSE

8.35

+0.35(+4.38%)

Updated at September 08 02:00PM

Currency In GBp

Allergy Therapeutics plc

Address

Dominion Way

Worthing, BN14 8SA

United Kingdom of Great Britain and Northern Ireland

Phone

44 1903 844 700

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

612

First IPO Date

October 11, 2004

Key Executives

NameTitlePayYear Born
Mr. Manuel LlobetChief Executive Officer & Executive Director484,5061965
Dr. Shaun Antony FurlongChief Financial Officer & Executive Director207,9311976
Ms. Sue BakerHead of Human Resources0N/A
Simon PiggottHead of Clinical Science0N/A
Mr. Matthew HeathPrincipal Scientist0N/A
Dr. Murray SkinnerChief Scientific Officer0N/A
Mr. Russell PicketGroup Financial Controller0N/A
Karley Charlotte Mouatt CheesmanCompany Secretary0N/A
Alan BullimoreHead of Communication & Market Development0N/A

Description

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.